Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates ... Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.61 | -12.7561837456 | 28.3 | 28.3 | 23.61 | 1082041 | 24.42433482 | CS |
| 4 | -1.85 | -6.9706103994 | 26.54 | 33.33 | 23.61 | 909618 | 27.3610084 | CS |
| 12 | 0.04 | 0.162271805274 | 24.65 | 33.33 | 23.61 | 870481 | 27.91104935 | CS |
| 26 | 4.79 | 24.0703517588 | 19.9 | 33.33 | 17.93 | 996321 | 24.51558962 | CS |
| 52 | 6.11 | 32.8848223897 | 18.58 | 33.33 | 14.56 | 1063060 | 21.62180267 | CS |
| 156 | -22.39 | -47.5573491929 | 47.08 | 48.46 | 14.56 | 814514 | 25.57223863 | CS |
| 260 | 7.59 | 44.3859649123 | 17.1 | 93.94 | 12.39 | 723841 | 32.20925891 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
